Pricing Log in Create free account
Saturday 17 October 2026 Export A’s income statement to Excel — free account

Agilent Technologies, Inc.

A Healthcare Diagnostics & Research

Agilent Technologies, Inc.’s revenue for fiscal 2025 (year ended October 2025) was $6.9 billion, up 6.73% from fiscal 2024. In the quarter to July 2026, revenue grew 8.06%, EPS grew 8.47%, free cash flow grew 69.5% and total debt rose 8.81%, each against the same quarter a year earlier. Member of the S&P 500; dividend growth for ten consecutive years.

172.96 2.59 −1.48%
Market cap
$49.5B
P/E
34.0×
Fwd P/E
26.3×
Dividend yield
0.59%
F-score
5/9
Altman Z
5.46
Beneish M
−2.46
Dividend safety
86/100
Overview Business Profile Financial Analysis Income Statement Balance Sheet Cash Flow Metrics & Ratios Filings 10-Q 10-K

Agilent Technologies, Inc. (A) EV/Sales

Alert me on EV/Sales

As of 16 October 2026, Agilent Technologies, Inc. (A) trades at a EV/Sales of 6.9×. Over the past ten years it has ranged from 2.2× (September 2015) to 9.1× (September 2021); the current reading is higher than 89% of that period. That is above the Diagnostics & Research industry median of 5.5× and above the Healthcare sector median of 3.4×.

EV/Sales, daily

Embed this chart

Annual newest first

Period EV/Sales Change
FY2025 6.2× 0.81%
FY2024 6.1× 32.49%
FY2023 4.6× (26.58%)
FY2022 6.3× (18.77%)
FY2021 7.7× 23.84%
FY2020 6.2× 33.35%
FY2019 4.7× 13.16%
FY2018 4.1× (11.93%)
FY2017 4.7× 42.99%
FY2016 3.3× 8.31%

Quarterly newest first

Period EV/Sales Change
Jul 2026 5.5× 18.63%
Apr 2026 4.7× (16.56%)
Jan 2026 5.6× (9.05%)
Oct 2025 6.2× 21.56%
43 more quarters

Against its own ten years

Low 2.2× High 9.1×
Ten-year median 5.1×
Current reading's percentile 88

EV/Sales against peers

Company EV/Sales
LH Labcorp Holdings Inc. compare 2.2×
DGX Quest Diagnostics Incorporated compare 2.7×
IQV IQVIA Holdings Inc. compare 3.4×
A Agilent Technologies, Inc. 6.9×
MTD Mettler-Toledo International, Inc. compare 8.4×
ILMN Illumina, Inc. compare 9.0×
IDXX IDEXX Laboratories, Inc. compare 9.8×
WAT Waters Corporation compare 10.2×
NTRA Natera, Inc. compare 20.5×
Diagnostics & Research industry median 5.5×
Healthcare sector median 3.4×
Market median 2.1×

What EV/Sales is

EV/Sales tells an investor how the value of a whole company, counting its debt and cash, compares with the sales it brings in.

((Stock Price × Shares (Basic, Weighted) (latest quarter)) + (Long Term Debt (Total) (latest quarter) + Current Part of Debt (latest quarter)) − Cash & Short Term Investments (latest quarter)) ÷ Revenue (TTM)

The full definition of EV/Sales →

More on A